InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,475.20
(
0.32%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.57
(
0.53%
)
Bitcoin
64,154.38
(
0.24%
)
Post# of 251721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mouton29

Send PM Follow Ignore
Followers 21
Posts 2022
Boards Moderated 0
Alias Born 04/14/2007

mouton29

Member Level

Re: vinmantoo post# 249547

Monday, 10/30/2023 11:55:13 PM

Monday, October 30, 2023 11:55:13 PM

Post# of 251721
I see the point when running a large trial v placebo. But running a 1000 or 2000 patient noninferiority trial v a drug with lots of side effects selling 1 million prescriptions a month— how hard is that to enroll? Who cares about seasonality? Seems to me that’s the least of ENTA’s problems.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up